Last update 18 Nov 2024

Evenus Pharmaceutical Laboratories, Inc.

Private Company|
2009|
United States

Overview

Tags

Infectious Diseases
Urogenital Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases1
Infectious Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
fungal CYP51A11

Related

1
Drugs associated with Evenus Pharmaceutical Laboratories, Inc.
Oteseconazole
Target
fungal CYP51A1
Mechanism
fungal CYP51A1 inhibitors
Active Org.
Evenus Pharmaceutical Laboratories, Inc. [+2]
Originator Org.
Mycovia Pharmaceuticals, Inc.Mycovia Pharmaceuticals, Inc.Startup
Active Indication
Candidiasis, Vulvovaginal [+4]
Inactive Indication
Recurrent candidiasis of vagina [+2]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date26 Apr 2022
6
Clinical Trials associated with Evenus Pharmaceutical Laboratories, Inc.
CTR20211991 / SuspendedPhase 3
评价SHR8008胶囊治疗复发性外阴阴道假丝酵母菌病(RVVC)的有效性与安全性的随机、双盲双模拟、氟康唑平行对照、多中心III期临床研究
[Translation] A randomized, double-blind, double-dummy, fluconazole-controlled, multicenter phase III clinical study to evaluate the efficacy and safety of SHR8008 capsules in the treatment of recurrent vulvovaginal candidiasis (RVVC)
CTR20210733 / CompletedPhase 3
评价SHR8008胶囊治疗急性外阴阴道假丝酵母菌病(VVC)的有效性与安全性的随机、双盲双模拟、氟康唑平行对照、多中心III期临床研究
[Translation] A randomized, double-blind, double-dummy, fluconazole-controlled, multicenter phase III clinical study to evaluate the efficacy and safety of SHR8008 capsules in the treatment of acute vulvovaginal candidiasis (VVC)
CTR20210163 / CompletedPhase 3
评价SHR8028滴眼液治疗干眼病的有效性和安全性-多中心、随机、双盲、赋形剂平行对照Ⅲ期临床试验
[Translation] Evaluation of the efficacy and safety of SHR8028 eye drops in the treatment of dry eye disease: a multicenter, randomized, double-blind, vehicle-controlled phase III clinical trial
100 Clinical Results associated with Evenus Pharmaceutical Laboratories, Inc.
Login to view more data
0 Patents (Medical) associated with Evenus Pharmaceutical Laboratories, Inc.
Login to view more data
100 Deals associated with Evenus Pharmaceutical Laboratories, Inc.
Login to view more data
100 Translational Medicine associated with Evenus Pharmaceutical Laboratories, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
2
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Oteseconazole
 ( fungal CYP51A1 )		Candidiasis, Vulvovaginal
More
Approved
Perfluorohexyloctane
 ( Lipid )		Meibomian Gland Dysfunction
More
Pending
Cyclosporine
 ( CaN )		Xerophthalmia
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free